Steve Schonfeld Schonfeld Strategic Advisors
Steve Schonfeld is the founder of Schonfeld Strategic Advisors, a multi-manager investment firm with roots in proprietary trading. Schonfeld allocates capital across quantitative and discretionary strategies with an emphasis on risk controls and diversification of return streams. The firm is a major name in the multi-strategy hedge fund landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TC Energy
TRP
|
+$113M |
| 2 |
Amazon
AMZN
|
+$61.7M |
| 3 |
Alibaba
BABA
|
+$39.9M |
| 4 |
CTEV
Claritev Corp
CTEV
|
+$30.3M |
| 5 |
WPF.U
Foley Trasimene Acquisition Corp.
WPF.U
|
+$28.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$37M |
| 2 |
CCXX.U
Churchill Capital Corp III Units, each consisting of one share of Class A Common Stock and one-fourt
CCXX.U
|
+$30M |
| 3 |
JD.com
JD
|
+$29.9M |
| 4 |
Bilibili
BILI
|
+$29.5M |
| 5 |
CCX.U
Churchill Capital Corp II
CCX.U
|
+$25.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.48% |
| 2 | Consumer Discretionary | 13.41% |
| 3 | Financials | 10.94% |
| 4 | Industrials | 10.2% |
| 5 | Healthcare | 9.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
UMPQ
951
DELISTED
Umpqua Holdings Corp
UMPQ
| $343K | 0.01% |
32,200
+9,181
| +40% | +$103K |
|
952
Sixth Street Specialty
TSLX
$1.8B
| $341K | 0.01% |
20,700
-6,400
| -24% | -$106K |
|
953
Agios Pharmaceuticals
AGIO
$1.95B
| $339K | 0.01% |
6,334
-134
| -2% | -$6.21K |
|
954
Green Plains
GPRE
$1.05B
| $336K | 0.01% |
+32,927
| New | +$243K |
|
955
Conduent
CNDT
$250M
| $335K | 0.01% |
140,233
+129,608
| +1,220% | +$301K |
|
956
Aprea Therapeutics
APRE
$10.1M
| $334K | 0.01% |
+430
| New | +$282K |
|
957
Lakeland Industries
LAKE
$112M
| $334K | 0.01% |
+14,900
| New | +$244K |
|
958
Unisys
UIS
$192M
| $332K | 0.01% |
+30,443
| New | +$352K |
|
959
Morgan Stanley
MS
$336B
| $331K | 0.01% |
6,843
-164,145
| -96% | -$6.89M |
|
|
AMRN
960
Amarin Corp
AMRN
$292M
| $330K | 0.01% |
+2,380
| New | +$327K |
|
|
SILK
961
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $330K | 0.01% |
7,883
-2,917
| -27% | -$112K |
|
962
OraSure Technologies
OSUR
$263M
| $326K | 0.01% |
+28,087
| New | +$365K |
|
963
Douglas Emmett
DEI
$2B
| $325K | 0.01% |
+10,596
| New | +$318K |
|
964
Flex
FLEX
$39.4B
| $325K | 0.01% |
+42,066
| New | +$303K |
|
|
TVRD
965
Tvardi Therapeutics
TVRD
$23.7M
| $324K | 0.01% |
+527
| New | +$291K |
|
966
Wipro
WIT
$18.6B
| $323K | 0.01% |
195,400
+158,200
| +425% | +$248K |
|
967
Strategy Inc
MSTR
$48.7B
| $322K | 0.01% |
+27,240
| New | +$331K |
|
|
ROIC
968
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $321K | 0.01% |
+28,300
| New | +$274K |
|
|
LOGM
969
DELISTED
LogMein, Inc.
LOGM
| $321K | 0.01% |
+3,781
| New | +$321K |
|
970
Direxion Daily Junior Gold Miners Index Bull 2X ETF
JNUG
$675M
| $320K | 0.01% |
+2,900
| New | +$244K |
|
971
Aclaris Therapeutics
ACRS
$929M
| $318K | 0.01% |
196,100
+173,834
| +781% | +$233K |
|
972
Hudbay
HBM
$13.1B
| $318K | 0.01% |
+105,204
| New | +$264K |
|
|
STSA
973
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
| $317K | 0.01% |
+11,000
| New | +$255K |
|
974
Banco Bradesco
BBD
$34.3B
| $316K | 0.01% |
100,430
+27,358
| +37% | +$83.3K |
|
975
TIM SA
TIMB
$8.69B
| $316K | 0.01% |
24,400
+10,500
| +76% | +$131K |
|
Similar funds
Steve Schonfeld's Q2 2020 Portfolio in Review
As of Q2 2020, Steve Schonfeld held 1,688 positions worth $3.89B, up 145% from $1.59B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Steve Schonfeld deployed $1.81B of net new capital in Q2 2020, opening 594 new positions and adding to 357 existing holdings. Its largest new stake was Claritev Corp: 75,000 shares worth $32.4M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was JD.com, an estimated $29.9M trimmed.
- Steve Schonfeld's largest Q2 2020 buy was Claritev Corp: 75,000 shares worth $32.4M.
- Steve Schonfeld added most to TC Energy in Q2 2020, an estimated $113M increase.
- Steve Schonfeld's biggest Q2 2020 reduction was JD.com, cutting an estimated $29.9M.
- Steve Schonfeld fully exited Allergan plc in Q2 2020, selling an estimated $37M.
- Steve Schonfeld's ten largest holdings make up 13% of its $3.89B portfolio in Q2 2020.
- Steve Schonfeld opened 594 new positions and closed 486 in Q2 2020.
- Steve Schonfeld's portfolio value rose 145% quarter-over-quarter to $3.89B.
Based on Schonfeld Strategic Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.